Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs-Reference-Cited by-同舟云学术

Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs

Published:2020-09 Issue: Volume:102 Page:104041
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Li Yi-Ming,Luo Rong-Hua,Yang Liu-Meng,Huang Si-Ming,Li Sui-Yuan,Zheng Yu-Gui,Ni Dong-Xuan,Cui Yi-Man,Zhang Xing-Jie,Li Xiao-Li,Zhang Rui-Han,Tang E,Zhang Hong-Bin,Zheng Yong-Tang,He Yan-Ping,Xiao Wei-Lie

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference48 articles.

1. UNAIDS. 2019AIDS epidemic update. https://www.unaids.org/en/resources/documents/2019 /2019-global-AIDS-update/.

2. The journey of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) from lab to clinic;Namasivayam;J. Med. Chem.,2019

3. Combined approaches for HIV cure;Margolis;Curr. Opin.,2013

4. Current status and challenges of antiretroviral research and therapy;Este;Antivir. Res.,2010

5. D. Finzi, M. Hermankova, T. Pierson, L. M. et al., Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy, Science. 278 (1997), 1295-300.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance;Medicinal Research Reviews;2024-08-26

2. Synthesis and anti‐HIV activity of non‐nucleoside reverse‐transcriptase inhibitor DB02 phosphate derivatives based on water‐soluble optimization;Drug Development Research;2023-02-08

3. Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present);Arabian Journal of Chemistry;2022-12

4. Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 Infection;Viruses;2022-10-28

5. C6-structural optimizations of 2-aryl-1H-pyrazole-S-DABOs: From anti-HIV to anti-DENV activity;Bioorganic Chemistry;2022-02